GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) » Definitions » Cyclically Adjusted Revenue per Share

Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Cyclically Adjusted Revenue per Share : ¥10.58 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥2.304. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥10.58 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Zhejiang Hisun Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was -6.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Zhejiang Hisun Pharmaceutical Co was 17.40% per year. The lowest was -1.60% per year. And the median was 8.70% per year.

As of today (2025-05-19), Zhejiang Hisun Pharmaceutical Co's current stock price is ¥9.02. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥10.58. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 0.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhejiang Hisun Pharmaceutical Co was 3.79. The lowest was 0.62. And the median was 1.24.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Zhejiang Hisun Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.93 11.39 11.76 11.36 10.86

Zhejiang Hisun Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.31 11.14 11.09 10.86 10.58

Competitive Comparison of Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Hisun Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.304/115.1156*115.1156
=2.304

Current CPI (Mar. 2025) = 115.1156.

Zhejiang Hisun Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.508 99.500 1.745
201509 2.039 100.500 2.336
201512 1.519 100.600 1.738
201603 2.353 102.200 2.650
201606 2.537 101.400 2.880
201609 2.689 102.400 3.023
201612 2.755 102.600 3.091
201703 2.805 103.200 3.129
201706 2.903 103.100 3.241
201709 2.864 104.100 3.167
201712 1.766 104.500 1.945
201803 2.876 105.300 3.144
201806 2.514 104.900 2.759
201809 2.559 106.600 2.763
201812 2.928 106.500 3.165
201903 2.909 107.700 3.109
201906 3.012 107.700 3.219
201909 2.740 109.800 2.873
201912 3.338 111.200 3.456
202003 2.590 112.300 2.655
202006 2.912 110.400 3.036
202009 2.951 111.700 3.041
202012 3.244 111.500 3.349
202103 2.904 112.662 2.967
202106 2.479 111.769 2.553
202109 2.528 112.215 2.593
202112 2.641 113.108 2.688
202203 2.424 114.335 2.441
202206 2.252 114.558 2.263
202209 2.537 115.339 2.532
202212 2.973 115.116 2.973
202303 2.242 115.116 2.242
202306 2.585 114.558 2.598
202309 2.232 115.339 2.228
202312 1.434 114.781 1.438
202403 2.304 115.227 2.302
202406 2.153 114.781 2.159
202409 2.267 115.785 2.254
202412 1.721 114.893 1.724
202503 2.304 115.116 2.304

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Zhejiang Hisun Pharmaceutical Co  (SHSE:600267) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.02/10.58
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhejiang Hisun Pharmaceutical Co was 3.79. The lowest was 0.62. And the median was 1.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Executives
Yu Shun Bing Supervisors
Jin Hong Shun senior management
Lu Xing Hai senior management
Zhang Zhen Ying senior management
Jiang Guo Ping Director
Yang Zhi Qing senior management
Du Jia Qiu senior management
Chen Xiao Hua Directors, senior managers
Li Yan Directors, senior managers
Zhao Lei senior management
Shen Xi Fei Director
Zhang Wei senior management
Bai Hua Director
Chen Li Fei Supervisors
Hu Liang Bin senior management

Zhejiang Hisun Pharmaceutical Co Headlines

No Headlines